TORONTO, September 3 /PRNewswire/ -- Therapure Biopharma Inc., a Canadian biopharmaceutical company, announced that it is open for business and has its first contracts with customers in biopharmaceutical development and manufacturing.
Located in Mississauga, Ontario, just 30 minutes from Toronto's Pearson International Airport, Therapure Biopharma provides clients with customized solutions for the development and manufacture of complex biological products. Leveraging its unique and flexible, 130,000 square foot cGMP manufacturing facility, its extensive quality systems, and the dedication of its highly experienced staff, Therapure Biopharma is able to develop effective and innovative solutions to advance therapeutic proteins from the lab to the market.
"We are more than just a contract manufacturing organization (CMO)," said Thomas G. Wellner, President and Chief Executive Officer. "The Company's scientific, manufacturing, and downstream purification expertise, combined with an intimate understanding of advanced biology, complex proteins, and the regulatory requirements for biological drugs, enables us to be a drug development partner with our clients."
Therapure Biopharma offers a wide range of value-added services covering all aspects of protein production so that the scale-up to commercial manufacture will not be a barrier to success. The Company's qualified staff has solved many of the manufacturing challenges facing clients, and the Company will partner with clients to solve their challenges. Many dynamic companies have access to novel, high-value protein-based products that are ready for commercialization but do not have the capabilities to move ahead alone. Therapure Biopharma can help by applying a deep understanding of the market and the business opportunities for protein-based therapeutics.
"We understand the complex regulatory processes for the registration of biological products and have established quality-based cGMP compliant manufacturing processes. We also understand and appreciate the confidential nature of your business and desire a long-term relationship," said Mr. Wellner. "Therapure Biopharma is your one-stop shop for pilot and commercial scale protein/API production, processing, filling, and finishing. We can address your scale-up challenges from bench to commercial scale. Partner with us and we will apply our expertise and proprietary technology to advance your products effectively."
Let Therapure Biopharma be a partner in bringing your biopharmaceutical products to the world. For more information, please visit the company's website at http://www.therapurebio.com. For further information: Thomas G. Wellner, President and CEO, Tel: +1-905-286-6204, email: firstname.lastname@example.org
Source: Therapure Biopharma Inc